Imaging is pivotal in the evaluation and management of patients with seizure disorders. Elegant structural neuroimaging with magnetic resonance imaging (MRI) may assist in determining the etiology of focal epilepsy and demonstrating the anatomical changes associated with seizure activity. The high diagnostic yield of MRI to identify the common pathological findings in individuals with focal seizures including mesial temporal sclerosis, vascular anomalies, low-grade glial neoplasms and malformations of cortical development has been demonstrated. Positron emission tomography (PET) is the most commonly performed interictal functional neuroimaging technique that may reveal a focal hypometabolic region concordant with seizure onset. Single photon emission computed tomography (SPECT) studies may assist performance of ictal neuroimaging in patients with pharmacoresistant focal epilepsy being considered for neurosurgical treatment. This chapter highlights neuroimaging developments and innovations, and provides a comprehensive overview of the imaging strategies used to improve the care and management of people with epilepsy.

Department of Neurology 2nd Faculty of Medicine Charles University Prague and Motol University Hospital Czech Republic

Division of Epilepsy Department of Neurology Mayo Clinic Rochester MN USA

National Institute of Neurological Disorders and Stroke Bethesda MD USA

University of Campinas Department of Neurology Campinas SP Brazil

Zobrazit více v PubMed

Ahnlide J-A, Rosén I, Lindén-Mickelsson Tech P, et al. Does SISCOM contribute to favorable seizure outcome after epilepsy surgery? Epilepsia. 2007;48:579–588. PubMed

Andermann F. Rasmussen’s syndrome. Stoneham, MA: Butterworth-Heinemann; 1991. Chronic encephalitis and epilepsy.

Andersen AR. 99mTc-D, L-hexamethylene-propyleneamine oxime (99mTc-HMPAO): basic kinetic studies of a tracer of cerebral blood flow. Cerebrovasc Brain Metab Rev. 1989;1:288–318. PubMed

Arruda F, Cendes F, Andermann F, et al. Mesial atrophy and outcome after amygdalohippocampectomy or temporal lobe removal. Ann Neurol. 1996;40:446–450. PubMed

Banati RB, Goerres GW, Myers R, et al. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen’s encephalitis. Neurology. 1999;53:2199–2203. PubMed

Barba C, Di Giuda D, Policicchio D, et al. Correlation between provoked ictal SPECT and depth recordings in adult drug-resistant epilepsy patients. Epilepsia. 2007;48(2):278–285. PubMed

Barkovich AJ, Truwit CL. Brain damage from perinatal asphyxia: correlation of MR findings with gestational age. AJNR. 1990;11:1087–1096. PubMed PMC

Barkovich AJ, Rowley HA, Andermann F. MR in partial epilepsy: value of high-resolution volumetric techniques. AJNR. 1995;16:339–343. PubMed PMC

Barkovich AJ, Guerrini R, Kuzniecky RI, et al. A developmental and genetic classification for malformations of cortical development: update 2012. Brain. 2012;135:1348–1369. PubMed PMC

Bastos AC, Comeau R, Andermann F, et al. Diagnosis of subtle focal dysplastic lesions: curvilinear multiplanar reformatting from three dimensional magnetic resonance imaging. Ann Neurol. 1999;46:88–94. PubMed

Bauer M, Karch R, Zeitlinger M, et al. In vivo P-glycoprotein function before and after epilepsy surgery. Neurology. 2014;83:1326–1331. PubMed PMC

Bell ML, Rao S, So EL, et al. Epilepsy surgery outcomes in temporal lobe epilepsy with a normal MRI. Epilepsia. 2009;50:2053–2060. PubMed PMC

Berg AT, Mathern GW, Bronen RA, et al. Frequency, prognosis and surgical treatment of structural abnormalities seen with magnetic resonance imaging in childhood epilepsy. Brain. 2009;132:2785–2797. PubMed PMC

Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia. 2010;51:676–685. PubMed

Bernasconi A, Bernasconi N, Bernhardt BC, et al. Advances in MRI for ‘cryptogenic’ epilepsies. Nat Rev Neurol. 2011;7:99–108. PubMed

Bertram EH. Temporal lobe epilepsy: where do the seizures really begin? Epilepsy Behav. 2009;14(Suppl 1):32–37. PubMed PMC

Bien CG, Szinay M, Wagner J, et al. Characteristics and surgical outcomes of patients with refractory magnetic resonance imaging-negative epilepsies. Arch Neurol. 2009;66:1491–1499. PubMed

Blumcke I, Thom M, Aronica E, et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia. 2011;52:158–174. PubMed PMC

Blumcke I, Aronica E, Urbach H, et al. A neuropathology-based approach to epilepsy surgery in brain tumors and proposal for a new terminology use for long-term epilepsy-associated brain tumors. Acta Neuropathol. 2014;128(1):39–54. PubMed PMC

Blumenfeld H, Varghese GI, Purcaro MJ, et al. Cortical and subcortical networks in human secondarily generalized tonic-clonic seizures. Brain. 2009;132(Pt 4):999–1012. PubMed PMC

Bouilleret V, Semah F, Biraben A, et al. Involvement of the basal ganglia in refractory epilepsy: an 18 F-fluoro-L-DOPA PET study using 2 methods of analysis. J Nucl Med. 2005;46:540–547. PubMed

Bouvard S, Costes N, Bonnefoi F, et al. Seizure-related short-term plasticity of benzodiazepine receptors in partial epilepsy: a [11C]flumazenil-PET study. Brain. 2005;128:1330–1343. PubMed

Brodtkorb E, Zuberi S, Gambardella A, et al. Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study. Brain. 2006;129:2047–2060. PubMed

Bromfield EB, Altshuler L, Leiderman DB, et al. Cerebral metabolism and depression in patients with complex partial seizures. Arch Neurol. 1992;49:617–623. PubMed

Bronen RA, Fulbright RK, Spencer DD, et al. Refractory epilepsy: comparison of MR imaging, CT, and histopathologic findings in 117 patients. Radiology. 1996;201(1):97–105. PubMed

Burdette DE, Sakurai SY, Henry TR, et al. Temporal lobe central benzodiazepine binding in unilateral mesial temporal lobe epilepsy. Neurology. 1995;45:934–941. PubMed

Butler T, Ichise M, Teich AF, et al. Imaging inflammation in a patient with epilepsy due to focal cortical dysplasia. J Neuroimaging. 2013;23:129–131. PubMed PMC

Carne RP, O’Brien TJ, Kilpatrick CJ, et al. MRI-negative PET-positive temporal lobe epilepsy: a distinct surgically remediable syndrome. Brain. 2004;127:2276–2285. PubMed

Cascino GD. Advances in neuroimaging: surgical localization. Epilepsia. 2001;42:3–12. PubMed

Cascino GD, Buchhalter JR, Mullan BP, et al. Ictal SPECT in nonlesional extratemporal epilepsy. Epilepsia. 2004;45(Suppl 4):32–34. PubMed

Cendes F. Neuroimaging in investigation of patients with epilepsy. Continuum (Minneap Minn) 623–642;19(3 Epilepsy) PubMed PMC

Cendes F, Knowlton RC, Novotny E, et al. Magnetic resonance spectroscopy in epilepsy: clinical issues. Epilepsia. 2002;43(Suppl. 1):32–39.

Cendes F, Sakamoto AC, Spreafico R, et al. Epilepsies associated with hippocampal sclerosis. Acta Neuropathol. 2014;128:21–37. PubMed

Chugani HT, Mazziotta JC, Engel J, Jr, et al. The Lennox-Gastaut syndrome: metabolic subtypes determined by 2-deoxy-2[18 F]fluoro-D-glucose positron emission tomography. Ann Neurol. 1987;21:4–13. PubMed

Chugani HT, Shields WD, Shewmon DA, et al. Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment. Ann Neurol. 1990;27:406–413. PubMed

Chugani HT, Shewmon DA, Shields WD, et al. Surgery for intractable infantile spasms: neuroimaging perspectives. Epilepsia. 1993;34:764–771. PubMed

Chugani HT, Kumar A, Kupsky W, et al. Clinical and histopathologic correlates of 11C–alpha-methyl-L-tryptophan (AMT) PET abnormalities in children with intractable epilepsy. Epilepsia. 2011;52:1692–1698. PubMed PMC

Chugani HT, Luat AF, Kumar A, et al. α-[11C]-Methyl-L-tryptophan-PET in 191 patients with tuberous sclerosis complex. Neurology. 2013;81:674–680. PubMed PMC

Chugani HT, Asano E, Juha´sz C, et al. Subtotal hemispherectomy in children with intractable focal epilepsy. Epilepsia. 2014;55:1926–1933. PubMed

Coan AC, Campos BM, Yasuda CL, et al. Frequent seizures are associated with a network of gray matter atrophy in temporal lobe epilepsy with or without hippocampal sclerosis. PLoS One. 2014;9(1):e85843. PubMed PMC

Colombo N, Salamon N, Raybaud C, et al. Imaging of malformations of cortical development. Epileptic Disord. 2009;11:194–205. PubMed

Commission on Neuroimaging of the International League Against Epilepsy. Recommendations for neuroim-aging of patients with epilepsy. Epilepsia. 1997;38:1255–1256. PubMed

Danfors T, Åhs F, Appel L, et al. Increased neurokinin-1 receptor availability in temporal lobe epilepsy: a positron emission tomography study using [(11) C]GR205171. Epilepsy Res. 2011;97:183–189. PubMed

Ding YS, Chen BB, Glielmi C, et al. A pilot study in epilepsy patients using simultaneous PET/MR. Am J Nucl Med Mol Imaging. 2014;4:459–470. PubMed PMC

Dupont P, Van Paesschen W, Palmini A, et al. Ictal perfusion patterns associated with single MRI-visible focal dysplastic lesions: implications for the noninvasive delineation of the epileptogenic zone. Epilepsia. 2006;47:1550–1557. PubMed

Engel J, Jr, Kuhl DE, Phelps ME, et al. Interictal cerebral glucose metabolism in partial epilepsy and its relation to EEG changes. Ann Neurol. 1982;12:510–517. PubMed

Engel J, Jr, Lubens P, Kuhl DE, et al. Local cerebral metabolic rate for glucose during petit mal absences. Ann Neurol. 1985;17:121–128. PubMed

Engel J, Jr, Henry TR, Risinger MW, et al. Presurgical evaluation for partial epilepsy: relative contributions of chronic depth-electrode recordings versus FDG-PET and scalp-sphenoidal ictal EEG. Neurology. 1990;40:1670–1677. PubMed

Feldmann M, Asselin MC, Liu J, et al. P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control study. Lancet Neurol. 2013;12:777–785. PubMed

Foldvary N, Lee N, Hanson MW, et al. Correlation of hippocampal neuronal density and FDG-PET in mesial temporal lobe epilepsy. Epilepsia. 1999;40:26–29. PubMed

Frost JJ, Mayberg HS, Fisher RS, et al. Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy. Ann Neurol. 1988;23:231–237. PubMed

Fujita M, Mahanty S, Zoghbi SS, et al. PET reveals inflammation around calcified Taenia solium granulomas with perilesional edema. PLoS One. 2013;8:e74052. PubMed PMC

Gaillard WD, Fazilat S, White S, et al. Interictal metabolism and blood flow are uncoupled in temporal lobe cortex of patients with complex partial epilepsy. Neurology. 1995;45:1841–1847. PubMed

Gaillard WD, Kopylev L, Weinstein S, et al. Low incidence of abnormal (18)FDG-PET in children with newonset partial epilepsy: a prospective study. Neurology. 2002;58:717–722. PubMed

Gaillard WD, Cross JH, Duncan JS, et al. Epilepsy imaging study guideline criteria: commentary on diagnostic testing study guidelines and practice parameters. Epilepsia. 2011;52(9):1750–1756. PubMed PMC

Garbelli R, Milesi G, Medici V, et al. Blurring in patients with temporal lobe epilepsy: clinical, high-field imaging and ultrastructural study. Brain. 2012;135(Pt 8):2337–2349. PubMed

Giovacchini G, Toczek MT, Bonwetsch R, et al. 5-HT 1A receptors are reduced in temporal lobe epilepsy after partial-volume correction. J Nucl Med. 2005;46:1128–1135. PubMed PMC

Gok B, Jallo G, Hayeri R, et al. The evaluation of FDG-PET imaging for epileptogenic focus localization in patients with MRI positive and MRI negative temporal lobe epilepsy. Neuroradiology. 2013;55:541–550. PubMed

Hasler G, Bonwetsch R, Giovacchini G, et al. 5-HT (1A) Receptor binding in temporal lobe epilepsy patients with and without major depression. Biol Psychiatry. 2007;62:1258–1264. PubMed PMC

Henry TR, Frey KA, Sackellares JC, et al. In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology. 1993;43:1998–2006. PubMed

Henry TR, Babb TL, Engel J, Jr, et al. Hippocampal neuronal loss and regional hypometabolism in temporal lobe epilepsy. Ann Neurol. 1994;36:925–927. PubMed

Hirvonen J, Kreisl WC, Fujita M, et al. In vivo expression of an inflammatory marker in temporal lobe epilepsy. J Nucl Med. 2012;53:234–240. PubMed PMC

Hogan RE, Carne RP, Kilpatrick CJ, et al. Hippocampal deformation mapping in MRI negative PET positive temporal lobe epilepsy. J Neurol Neurosurg Psychiatry. 2008;79:636–640. PubMed

Holmes MD, Kutsy RL, Ojemann GA, et al. Interictal, unifocal spikes in refractory extratemporal epilepsy predict ictal origin and postsurgical outcome. Clin Neurophysiol Off J Int Fed Clin Neurophysiol. 2000;111:1802–1808. PubMed

Hong SJ, Kim H, Schrader D, et al. Automated detection of cortical dysplasia type II in MRI-negative epilepsy. Neurology. 2014;83(1):48–55. PubMed PMC

Iinuma K, Yokoyama H, Otsuki T, et al. Histamine H1 receptors in complex partial seizures. Lancet. 1993;341:238. PubMed

Itomi K, Okumura A, Negoro T, et al. Prognostic value of positron emission tomography in cryptogenic West syndrome. Dev Med Child Neurol. 2002;44:107–111. PubMed

Jack CRJ, Sharbrough FW, Cascino GD, et al. Magnetic resonance image-based hippocampal volumetry: correlation with outcome after temporal lobectomy. Ann Neurol. 1992;31:138–146. PubMed

Jayakar P, Dunoyer C, Dean P, et al. Epilepsy surgery in patients with normal or nonfocal MRI scans: integrative strategies offer long-term seizure relief. Epilepsia. 2008;49(5):758–764. PubMed

Joo EY, Lee EK, Tae WS, et al. Unitemporal vs bitemporal hypometabolism in mesial temporal lobe epilepsy. Arch Neurol. 2004;61:1074–1078. PubMed

Josephson CB, Dykeman J, Fiest KM, et al. Systematic review and meta-analysis of standard vs selective temporal lobe epilepsy surgery. Neurology. 2013;80(18):1669–1676. PubMed

Kaminska A, Chiron C, Ville D, et al. Ictal SPECT in children with epilepsy: comparison with intracranial EEG and relation to postsurgical outcome. Brain. 2003;126:248–260. PubMed

Kassubek J, Huppertz H-J, Spreer J, et al. Detection and localization of focal cortical dysplasia by voxel-based 3-D MRI analysis. Epilepsia. 2002;43:596–602. PubMed

Kazemi NJ, Worrell GA, Stead SM, et al. Ictal SPECT statistical parametric mapping in temporal lobe epilepsy surgery. Neurology. 2010;74:70–76. PubMed PMC

Kim YK, Lee DS, Lee SK, et al. (18)F-FDG PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis. J Nucl Med. 2002;43:1167–1174. PubMed

Kim YK, Lee DS, Lee SK, et al. Differential features of metabolic abnormalities between medial and lateral temporal lobe epilepsy: quantitative analysis of (18)F-FDG PET using SPM. J Nucl Med. 2003;44:1006–1012. PubMed

Kim MA, Heo K, Choo MK, et al. Relationship between bilateral temporal hypometabolism and EEG findings for mesial temporal lobe epilepsy: analysis of 18 F-FDG PET using SPM. Seizure. 2006;15:56–63. PubMed

Knake S, Triantafyllou C, Wald LL, et al. 3 T phased array MRI improves the presurgical evaluation in focal epilepsies: a prospective study. Neurology. 2005;65:1026–1031. PubMed

Knopman AA, Wong CH, Stevenson RJ, et al. The cognitive profile of occipital lobe epilepsy and the selective association of left temporal lobe hypometabolism with verbal memory impairment. Epilepsia. 2014;55:e80–e84. PubMed

Koepp MJ, Hammers A, Labbe C, et al. 11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI. Neurology. 2000;54:332–339. PubMed

Koh S, Jayakar P, Dunoyer C, et al. Epilepsy surgery in children with tuberous sclerosis complex: presurgical evaluation and outcome. Epilepsia. 2000;41(9):1206–1213. PubMed

Koutroumanidis M, Hennessy MJ, Seed PT, et al. Significance of interictal bilateral temporal hypometabolism in temporal lobe epilepsy. Neurology. 2000;54:1811–1821. PubMed

Krsek P, Kudr M, Jahodova A, et al. Localizing value of ictal SPECT is comparable to MRI and EEG in children with focal cortical dysplasia. Epilepsia. 2013;54(2):351–358. PubMed

Kumlien E, Hartvig P, Valind S, et al. NMDA-receptor activity visualized with (S)-[N-methyl-11C]ketamine and positron emission tomography in patients with medial temporal lobe epilepsy. Epilepsia. 1999;40:30–37. PubMed

Kumlien E, Nilsson A, Hagberg G, et al. PET with 11C–deuterium-deprenyl and 18 F-FDG in focal epilepsy. Acta Neurol Scand. 2001;103:360–366. PubMed

Kuzniecky RI, Bilir E, Gilliam F, et al. Multimodality MRI in mesial temporal sclerosis: relative sensitivity and specificity. Neurology. 1997;49(3):774–778. PubMed

Labate A, Gambardella A, Aguglia U, et al. Temporal lobe abnormalities on brain MRI in healthy volunteers: a prospective case-control study. Neurology. 2010;74:553–557. PubMed

Lamusuo S, Pitkanen A, Jutila L, et al. [11 C] Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology. Neurology. 2000;54:2252–2260. PubMed

Lee JD, Kim H-J, Lee BI, et al. Evaluation of ictal brain SPET using statistical parametric mapping in temporal lobe epilepsy. Eur J Nucl Med Mol Imaging. 2000;27:1658–1665. PubMed

Lee JJ, Lee SK, Lee S-Y, et al. Frontal lobe epilepsy: clinical characteristics, surgical outcomes and diagnostic modalities. Seizure. 2008;17(6):514–523. PubMed

Lee JY, Joo EY, Park HS, et al. Repeated ictal SPECT in partial epilepsy patients: SISCOM analysis. Epilepsia. 2011;52:2249–2256. PubMed

Leiderman DB, Albert P, Balish M, et al. The dynamics of metabolic change following seizures as measured by positron emission tomography with fludeoxyglucose F 18. Arch Neurol. 1994;51:932–936. PubMed

Lippé S, Poupon C, Cachia A, et al. White matter abnormalities revealed by DTI correlate with interictal grey matter FDG-PET metabolism in focal childhood epilepsies. Epileptic Disord. 2012;14:404–413. PubMed

LoPinto-Khoury C, Sperling MR, Skidmore C, et al. Surgical outcome in PET-positive, MRI-negative patients with temporal lobe epilepsy. Epilepsia. 2012;53:342–348. PubMed

Lv RJ, Sun ZR, Cui T, et al. Temporal lobe epilepsy with amygdala enlargement: a subtype of temporal lobe epilepsy. BMC Neurol. 2014;14:194. PubMed PMC

Martinez A, Finegersh A, Cannon DM, et al. The 5-HT1A receptor and 5-HT transporter in temporal lobe epilepsy. Neurology. 2013;80:1465–1471. PubMed PMC

Mayberg HS, Sadzot B, Meltzer CC, et al. Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography. Ann Neurol. 1991;30:3–11. PubMed

McNally KA, Paige AL, Varghese G, et al. Localizing value of ictal-interictal SPECT analyzed by SPM (ISAS) Epilepsia. 2005;46:1450–1464. PubMed

Merlet I, Ostrowsky K, Costes N, et al. 5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18 F]MPPF-PET study. Brain. 2004;127:900–913. PubMed

Metsahonkala L, Gaily E, Rantala H, et al. Focal and global cortical hypometabolism in patients with newly diagnosed infantile spasms. Neurology. 2002;58:1646–1651. PubMed

Mittal S, Mittal M, Montes JL, et al. Hypothalamic hamartomas. Part 1. Clinical, neuroimaging, and neurophysiological characteristics. Neurosurg Focus. 2013;34(6):E6. PubMed

Mishra AM, Ellens DJ, Schridde U, et al. Where fMRI and electrophysiology agree to disagree: corticothalamic and striatal activity patterns in the WAG/Rij rat. J Neurosci. 2011;31:15053–15064. PubMed PMC

Montenegro MA, Cendes F, Lopes-Cendes I, et al. The clinical spectrum of malformations of cortical development. Arq Neuropsiquiatr. 2007;65(2A):196–201. PubMed

Mosbah A, Tramoni E, Guedj E, et al. Clinical, neuropsychological, and metabolic characteristics of transient epileptic amnesia syndrome. Epilepsia. 2014;55:699–706. PubMed

Mosewich R, So E, O’Brien T. Factors predictive of the outcome of frontal lobe epilepsy surgery. Epilepsia. 2000;41(7):843–849. PubMed

Muller-Gartner HW, Mayberg HS, Fisher RS, et al. Decreased hippocampal muscarinic cholinergic receptor binding measured by 123I-iododexetimide and single-photon emission computed tomography in epilepsy. Ann Neurol. 1993;34:235–238. PubMed

Muzik O, da Silva EA, Juhasz C, et al. Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy. Neurology. 2000;54:171–179. PubMed

Newey CR, Wong C, Wang ZI, et al. Optimizing SPECT SISCOM analysis to localize seizure-onset zone by using varying z scores. Epilepsia. 2013;54:793–800. PubMed

Noe K, Sulc V, Wong-Kisiel L, et al. Long-term outcomes after nonlesional extratemporal lobe epilepsy surgery. JAMA Neurol. 2013;70:1003–1008. PubMed PMC

O’Brien T, O’Connor M, Mullan B, et al. Subtraction ictal SPET co-registered to MRI in partial epilepsy: description and technical validation of the method with phantom and patient studies. Nucl Med Comm. 1998a;19:31–45. PubMed

O’Brien TJ, So EL, Mullan BP, et al. Subtraction ictal SPECT co-registered to MRI improves clinical usefulness of SPECT in localizing the surgical seizure focus. Neurology. 1998b;50:445–454. PubMed

O’Brien TJ, So EL, Mullan BP, et al. Subtraction SPECT co-registered to MRI improves postictal SPECT localization of seizure foci. Neurology. 1999;52:137–146. PubMed

O’Brien TJ, So EL, Mullan BP, et al. Subtraction periictal SPECT is predictive of extratemporal epilepsy surgery outcome. Neurology. 2000;55:1668–1677. PubMed

O’Brien TJ, Newton MR, Cook MJ, et al. Hippocampal atrophy is not a major determinant of regional hypometabolism in temporal lobe epilepsy. Epilepsia. 1997;38:74–80. PubMed

O’Brien TJ, Hicks RJ, Ware R, et al. The utility of a 3-dimensional, large-field-of-view, sodium iodide crystal-based PET scanner in the presurgical evaluation of partial epilepsy. J Nucl Med. 2001;42:1158–1165. PubMed

O’Brien TTJ, So EL, Cascino GD, et al. Subtraction SPECT coregistered to MRI in focal malformations of cortical development: localization of the epileptogenic zone in epilepsy surgery candidates. Epilepsia. 2004;45(4):367–376. PubMed

Odano I, Varrone A, Savic I, et al. Quantitative PET analyses of regional [11C]PE2I binding to the dopamine transporter-application to juvenile myoclonic epilepsy. Neuroimage. 2012;59:3582–3593. PubMed

Osborn AG, Salzman KL, Barkovich AJ, editors. Diagnostic Imaging: Brain. 2nd. Philadelphia: Amirsys/Lippincott Williams and Wilkins; 2010.

Patel KS, Zhao M, Ma H, et al. Imaging preictal hemodynamic changes in neocortical epilepsy. Neurosurg Focus. 2013;34(4):E10. PubMed PMC

Pearl PL, Gibson KM, Quezado Z, et al. Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiency. Neurology. 2009;73:423–429. PubMed PMC

Perissinotti A, Setoain X, Aparicio J, et al. Clinical role of subtraction ictal SPECT coregistered to MR imaging and (18)F-FDG PET in pediatric epilepsy. J Nucl Med. 2014;55(7):1099–1105. PubMed

Pisano T, Barkovich AJ, Leventer RJ, et al. Peritrigonal and temporo-occipital heterotopia with corpus callosum and cerebellar dysgenesis. Neurology. 2012;79:1244–1251. PubMed PMC

Poduri A, Golja A, Takeoka M, et al. Focal cortical malformations can show asymmetrically higher uptake on interictal fluorine-18 fluorodeoxyglucose positron emission tomography (PET) J Child Neurol. 2007;22:232–237. PubMed

Prevett MC, Duncan JS, Jones T, et al. Demonstration of thalamic activation during typical absence seizures using H2(15)O and PET. Neurology. 1995;45:1396–1402. PubMed

Radhakrishnan K, So EL, Silbert PL, et al. Predictors of outcome of anterior temporal lobectomy for intractable epilepsy. Neurology. 1998;51:465–471. PubMed

Rathore C, Dickson JC, Teotónio R, et al. The utility of 18 F-fluorodeoxyglucose PET (FDG PET) in epilepsy surgery. Epilepsy Res. 2014;108:1306–1314. PubMed

Rubi S, Costes N, Heckemann RA. Positron emission tomography with α-[11C]methyl-L-tryptophan in tuberous sclerosis complex-related epilepsy. Epilepsia. 2013;54:2143–2150. PubMed

Ryvlin P, Bouvard S, Le Bars D, et al. Clinical utility of flumazenil-PET versus [18 F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. Brain. 1998;121:2067–2081. PubMed

Saavalainen T, Jutila L, Mervaala E, et al. Temporal anteroinferior encephalocele: an underrecognized etiology of temporal lobe epilepsy? Neurology. 2015;85(17):1467–1474. PubMed

Salamon N, Kung J, Shaw SJ, et al. FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy. Neurology. 2008;71(20):1594–1601. PubMed PMC

Salzberg M, Taher T, Davie M, et al. Depression in temporal lobe epilepsy surgery patients: an FDG-PET study. Epilepsia. 2006;47:2125–2130. PubMed

Savic I, Persson A, Roland P, et al. In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet. 1988;2:863–866. PubMed

Savic I, Altshuler L, Baxter L, et al. Pattern of interictal hypometabolism in PET scans with fludeoxyglucose F 18 reflects prior seizure types in patients with mesial temporal lobe seizures. Arch Neurol. 1997;54:129–136. PubMed

Savic I, Lindstrom P, Gulyas B, et al. Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy. Neurology. 2004;62:1343–1351. PubMed

Scheinost D, Teisseyre TZ, Distasio M, et al. New open-source ictal SPECT analysis method implemented in BioImage Suite. Epilepsia. 2010;51(4):703–707. PubMed PMC

Sequeira KM, Tabesh A, Sainju RK, et al. Perfusion network shift during seizures in medial temporal lobe epilepsy. PLoS One. 2013;8(1):e53204. PubMed PMC

Sperling MR, Alavi A, Reivich M, et al. False lateralization of temporal lobe epilepsy with FDG positron emission tomography. Epilepsia. 1995;36:722–727. PubMed

Swartz BE, Brown C, Mandelkern MA, et al. The use of 2-deoxy-2-[18 F]fluoro-D-glucose (FDG-PET) positron emission tomography in the routine diagnosis of epilepsy. Mol Imaging Biol. 2002;4:245–252. PubMed

Tae WS, Joo EY, Kim JH, et al. Cerebral perfusion changes in mesial temporal lobe epilepsy: SPM analysis of ictal and interictal SPECT. Neuroimage. 2005;24:101–110. PubMed

Tan KM, Britton JW, Buchhalter JR, et al. Influence of subtraction ictal SPECT on surgical management in focal epilepsy of indeterminate localization: a prospective study. Epilepsy Res. 2008;82(2–3):190–193. PubMed

Taylor DC, Falconer MA, Bruton CJ, et al. Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry. 1971;34:369–387. PubMed PMC

Teixeira RA, Li LM, Santos SL, et al. Early development destructive brain lesions and their relationship to epilepsy and hippocampal damage. Brain Dev. 2003;25(8):560–570. PubMed

Téllez-Zenteno JF, Hernández Ronquillo L, Moien-Afshari F, et al. Surgical outcomes in lesional and nonlesional epilepsy: a systematic review and meta-analysis. Epilepsy Res. 2010;89:310–318. PubMed

Tenney JR, Rozhkov L, Horn P, et al. Cerebral glucose hypometabolism is associated with mitochondrial dysfunction in patients with intractable epilepsy and cortical dysplasia. Epilepsia. 2014;55:1415–1422. PubMed

Tepmongkol S, Srikijvilaikul T, Vasavid P. Factors affecting bilateral temporal lobe hypometabolism on 18 F-FDG PET brain scan in unilateral medial temporal lobe epilepsy. Epilepsy Behav. 2013;29:386–389. PubMed

Theodore WH, Newmark ME, Sato S, et al. [18 F]fluor-odeoxyglucose positron emission tomography in refractory complex partial seizures. Ann Neurol. 1983;14:429–437. PubMed

Theodore WH, Brooks R, Margolin R, et al. Positron emission tomography in generalized seizures. Neurology. 1985;35:684–690. PubMed

Theodore WH, Rose D, Patronas N, et al. Cerebral glucose metabolism in the Lennox-Gastaut syndrome. Ann Neurol. 1987;21:14–21. PubMed

Theodore WH, Sato S, Kufta C, et al. Temporal lobectomy for uncontrolled seizures: the role of positron emission tomography. Ann Neurol. 1992a;32:789–794. PubMed

Theodore WH, Carson RE, Andreasen P, et al. PET imaging of opiate receptor binding in human epilepsy using [18 F]cyclofoxy. Epilepsy Res. 1992b;13:129–139. PubMed

Theodore WH, Gaillard WD, De Carli C, et al. Hippocampal volume and glucose metabolism in temporal lobe epileptic foci. Epilepsia. 2001;42:130–132. PubMed

Theodore WH, Hasler G, Giovacchini G, et al. Reduced hippocampal 5HT1A PET receptor binding and depression in temporal lobe epilepsy. Epilepsia. 2007;48:1526–1530. PubMed

Theodore WH, Martinez AR, Khan OI, et al. PET imaging of serotonin 1A receptors and cerebral glucose metabolism for temporal lobectomy. J Nucl Med. 2012a;53:1375–1382. PubMed PMC

Theodore WH, Wiggs EA, Martinez AR, et al. Serotonin 1A receptors, depression, and memory in temporal lobe epilepsy. Epilepsia. 2012b;53:129–133. PubMed PMC

Thom M, Blu¨mcke I, Aronica E. Long-term epilepsy-associated tumors. Brain Pathol. 2012;22(3):350–379. PubMed PMC

Toczek MT, Carson RE, Lang L, et al. PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology. 2003;60:749–756. PubMed

Van Gompel JJ, Worrell GA, Bell ML, et al. Intracranial electroencephalography with subdural grid electrodes: techniques, complications, and outcomes. Neurosurgery. 2008;63(3):498–505. PubMed

Van Paesschen W, Dupont P, Sunaert S, et al. The use of SPECT and PET in routine clinical practice in epilepsy. Curr Opin Neurol. 2007;20:194–202. PubMed

van’t Klooster MA, Huiskamp G, Zijlmans M, et al. Can we increase the yield of FDG-PET in the preoperative work-up for epilepsy surgery? Epilepsy Res. 2014;108:1095–1105. PubMed

Varghese GI, Purcaro MJ, Motelow JE, et al. Clinical use of ictal SPECT in secondarily generalized tonic-clonic seizures. Brain. 2009;132(Pt 8):2102–2113. PubMed PMC

Victoroff JI, Benson F, Grafton ST, et al. Depression in complex partial seizures. Electroencephalography and cerebral metabolic correlates. Arch Neurol. 1994;51:155–163. PubMed

Vinton AB, Carne R, Hicks RJ, et al. The extent of resection of FDG-PET hypometabolism relates to outcome of temporal lobectomy. Brain. 2007;130:548–560. PubMed

Vivash L, Gregoire MC, Lau EW, et al. 18 F-flumazenil: a γ-aminobutyric acid A-specific PET for the localization of drug-resistant temporal lobe epilepsy. Radiotracer J Nucl Med. 2013;54:1270–1277. PubMed

Von Oertzen J, Urbach H, Jungbluth S, et al. Standard magnetic resonance imaging is inadequate for patients with refractory focal epilepsy. J Neurol Neurosurg Psychiatry. 2002;73(6):643–647. PubMed PMC

Von Oertzen TJ, Mormann F, Urbach H, et al. Prospective use of subtraction ictal SPECT coregistered to MRI (SISCOM) in presurgical evaluation of epilepsy. Epilepsia. 2011;52:2239–2248. PubMed

Wang DD, Blu¨mcke I, Coras R, et al. Sturge-Weber syndrome is associated with cortical dysplasia ILAE type IIIc and excessive hypertrophic pyramidal neurons in brain resections for intractable epilepsy. Brain Pathol. 2015;25(3):248–255. PubMed PMC

Weitemeyer L, Kellinghaus C, Weckesser M, et al. The prognostic value of [F]FDG-PET in nonrefractory partial epilepsy. Epilepsia. 2005;46:1654–1660. PubMed

Wiebe S, Blume WWT, Girvin JP, et al. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345(5):311–318. PubMed

Willmann O, Wennberg R, May T, et al. The contribution of 18 F-FDG PET in preoperative epilepsy surgery evaluation for patients with temporal lobe epilepsy: a meta-analysis. Seizure. 2007;16:509–520. PubMed

Winston GP, Yogarajah M, Symms MR, et al. Diffusion tensor imaging tractography to visualize the relationship of the optic radiation to epileptogenic lesions prior to neurosurgery. Epilepsia. 2011;52:1430–1438. PubMed PMC

Wong CH, Bleasel A, Wen L, et al. The topography and significance of extratemporal hypometabolism in refractory mesial temporal lobe epilepsy examined by FDG-PET. Epilepsia. 2010;51:1365–1373. PubMed

Wong CH, Bleasel A, Wen L, et al. Relationship between preoperative hypometabolism and surgical outcome in neocortical epilepsy surgery. Epilepsia. 2012;53:1333–1340. PubMed

Yang PF, Pei JS, Zhang HJ, et al. Long-term epilepsy surgery outcomes in patients with PET-positive, MRI-negative temporal lobe epilepsy. Epilepsy Behav. 2014;41:91–97. PubMed

Yankam Njiwa J, Bouvard S, Catenoix H, et al. Periventricular [(11)C]flumazenil binding for predicting postoperative outcome in individual patients with temporal lobe epilepsy and hippocampal sclerosis. Neuroimage Clin. 2013;3:242–248. PubMed PMC

Yasuda CL, Cendes F. Neuroimaging for the prediction of response to medical and surgical treatment in epilepsy. Expert Opin Med Diagn. 2012;6:295–308. PubMed

Zijlmans M, de Kort GA, Witkamp TD, et al. 3 T versus 1.5 T phased-array MRI in the presurgical work-up of patients with partial epilepsy of uncertain focus. J Magn Reson Imaging. 2009;30:256–262. PubMed

Zubal IG, Spencer SS, Imam K, et al. Difference images calculated from ictal and interictal technetium-99 m-HMPAO SPECT scans of epilepsy. J Nucl Med. 1995;36:684–689. PubMed